{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Gilead Sciences", "item": "https://www.patentleaderboard.com/company/gilead-sciences"}, {"@type": "ListItem", "position": 3, "name": "Katrien Brak", "item": "https://www.patentleaderboard.com/inventor/fl:ka_ln:brak-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
KB

Katrien Brak — 7 Patents

GSGilead Sciences: 7 patents #209 of 952Top 25%
Belmont, CA: #444 of 1,494 inventorsTop 30%
California: #83,669 of 386,348 inventorsTop 25%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Katrien Brak has been granted 7 US patents while listed as an inventor at Gilead Sciences. The first was granted in 2020 and the most recent in September 2025. Katrien Brak ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Katrien Brak in Belmont, CA, US.

Patents per Year

Patents granted per year, 2020 to 2025Bar chart with a peak of 2 patents in 2022.peak 22020: 1 patents20202022: 2 patents20222023: 2 patents20232024: 1 patents20242025: 1 patents2025

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12410146 Processes and intermediates for preparing MCL1 inhibitors Kae M. Bullock, Greg Cizio, Kathy Dao, Darryl David Dixon, Joshua R. Dunetz +11 more 2025-09-09
12030906 Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate Ernest A. Carra, Lars V. Heumann, Nate Larson 2024-07-09 $175,383,000
11760736 Processes and intermediates for preparing MCL1 inhibitors Kae M. Bullock, Greg Cizio, Kathy Dao, Darryl David Dixon, Joshua R. Dunetz +11 more 2023-09-19 $279,299,000
11597742 Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate Ernest A. Carra, Lars V. Heumann, Nate Larson 2023-03-07 $321,928,000
11344565 Methods for the preparation of ribosides Steven D. Axt, Pavel R. Badalov, Silvio Campagna, Andrei Chtchemelinine, Edward Doerffler +19 more 2022-05-31 $389,855,000
11325891 Processes and intermediates for preparing MCL1 inhibitors Kae M. Bullock, Greg Cizio, Kathy Dao, Darryl David Dixon, Joshua R. Dunetz +11 more 2022-05-10 $207,189,000
10836787 Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate Ernest A. Carra, Lars V. Heumann, Nate Larson 2020-11-17 $177,245,000